Investegate |NOVARTIS AG CHF0.50(REGD) Announcements | NOVARTIS AG CHF0.50(REGD): New data at ASH spotlight Novartis recently approved Scemblix®, next-generation CAR-T platform and expanding hematology portfolio

Investegate announcements from NOVARTIS AG CHF0.50(REGD), New data at ASH spotlight Novartis recently approved Scemblix®, next-generation CAR-T platform and expanding hematology portfolio

Related Keywords

United States ,Philadelphia ,Pennsylvania ,America ,American ,Isabella Zinck ,Thomas Hungerbuehler ,Susanne Schaffert ,Samir Shah ,Parag Mahanti ,Julie Masow ,Sloan Simpson ,Promacta Revolade ,Alina Levchuk ,Twitter ,Drug Administration ,Incyte Corporation As Jakafi ,Novartis Us External Communications ,Novartis External Communications ,Novartis ,Exchange Commission ,American Society Of Hematology ,Novartis Hematology Communications ,Incyte Corporation ,American Society ,Annual Meeting ,First In Human Study ,Diffuse Largeb Cell Lymphoma ,Fully Human ,Refractory Multiple Myeloma Manufactured ,Malignant Hematology ,Combination With Hypomethylating Agents ,With Very ,High Risk Myelodysplastic Syndrome ,Acute Myeloid Leukemia ,Final Analysis From ,Phase Ib Study ,Safety Results ,Patients With Chronic Myeloid Leukemia ,Chronic Phase After ,Tyrosine Kinase Inhibitors ,Update After ,Open Label ,Randomized Phase ,Once Daily ,Chronic Phase ,Pediatric Patients With Philadelphia Chromosome ,Chronic Myeloid Leukemia ,Chronic Phase Treated With ,Tyrosine Kinase Inhibitor ,Reported Outcomes ,Among Patients With Steroid Refractory ,Dependent Chronic Graft Vs Host Disease ,Best Available Therapy ,Month Analysis ,Paroxysmal Nocturnal Hemoglobinuria ,Efficacy Results From ,Kids Trial ,Adolescents With Sickle Cell Disease ,Two Antip Selectin Monoclonal Antibodies ,Crizanlizumab Shows Comparable ,Eltrombopag Combined With Cyclosporine ,First Line Therapy ,Adults With Severe Acquired Aplastic Anemia ,Interventional Phase ,Sickle Cell Disease ,National Alliance ,Sickle Cell Centers Study ,Investegate Announcements ,Investegate Company Announcements ,Ovartis Ag Chf0 50 Regd ,Lobenewswire ,Lobenewswire And Globenewswire ,Nw ,